Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Nicola Lehners"'
Autor:
Marc S. Raab, Kai Neben, Hartmut Goldschmidt, Anthony D. Ho, Peter Schirmacher, Andreas von Deimling, Thorsten Zenz, Jennifer Huellein, Christoph Heining, Roland Penzel, David Capper, Nicola Lehners, Mindaugas Andrulis
PDF file - 54K, Detailed clinical course of all BRAF-mutated patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24f1eb30c40dab1065565cb9a749c6c3
https://doi.org/10.1158/2159-8290.22530831
https://doi.org/10.1158/2159-8290.22530831
Publikováno v:
Emerging Infectious Diseases, Vol 19, Iss 5, Pp 748-755 (2013)
We studied risk factors for a severe clinical outcome in hospitalized patients with laboratory-confirmed influenza A(H1N1)pdm09 infection at the University Hospital Heidelberg in the pandemic and first postpandemic seasons. We identified 102 patients
Externí odkaz:
https://doaj.org/article/732a64e574334f629f8c1725d55dd435
Autor:
Nicola Lehners, Julia Tabatabai, Christiane Prifert, Marianne Wedde, Joe Puthenparambil, Benedikt Weissbrich, Barbara Biere, Brunhilde Schweiger, Gerlinde Egerer, Paul Schnitzler
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148258 (2016)
Respiratory viruses are a cause of upper respiratory tract infections (URTI), but can be associated with severe lower respiratory tract infections (LRTI) in immunocompromised patients. The objective of this study was to investigate the genetic variab
Externí odkaz:
https://doaj.org/article/20166f8ba6db4566a5b64ab5e18ba779
Autor:
Jing Xu, Jens Hillengass, Hartmut Goldschmidt, Jonas Leichsenring, Albrecht Stenzinger, Nicola Lehners, Elena Ellert, Mindaugas Andrulis, Marc S. Raab
Publikováno v:
Leukemia & Lymphoma. 59:2660-2669
Oncogene-induced senescence (OIS) is a cellular tumor-suppressive mechanism present in several premalignant conditions. Here, we analyze the possible impact of OIS on malignant transformation in plasma cell disorders. Tumor samples from 125 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::972976d8731c6acd65a6fe25e8cce071
https://doi.org/10.1080/10428194.2018.1443450
https://doi.org/10.1080/10428194.2018.1443450
Autor:
Sibylle C. Mellinghoff, Enrico Schalk, Antonio Vena, Nicola Lehners, Andrzej Plis, Stefan Hagel, Oliver A. Cornely, Daniela Dörfel, Matteo Bassetti
Publikováno v:
Mycoses. 61:256-260
Isavuconazole is a novel antifungal drug approved for the treatment of adults with invasive aspergillosis and mucormycosis. While azoles as a class effect are known to prolong QTc interval, clinical trials have shown that isavuconazole administration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f60cbfbf8c9386ee3d8c795a7e27a4e
https://doi.org/10.1111/myc.12731
https://doi.org/10.1111/myc.12731
Publikováno v:
Journal of Clinical Virology. 98:10-17
Background Respiratory syncytial virus (RSV) can be associated with severe disease and prolonged shedding in immunocompromised patients. Objective To investigate the genetic variability of RSV in consecutive samples of haematological patients with pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fb416fa0aadff26afcafeededf4f16b
https://doi.org/10.1016/j.jcv.2017.11.003
https://doi.org/10.1016/j.jcv.2017.11.003
Autor:
Xiang Zhou, Martin Cremer, Juliane Brandt, Mathias Witzens-Harig, Mark Kriegsmann, Anthony D. Ho, Nicola Lehners, Katharina Lisenko
Publikováno v:
Annals of Hematology. 97:351-354
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6eb232639c4a1e06f06cbd610e20eef
https://doi.org/10.1007/s00277-017-3124-5
https://doi.org/10.1007/s00277-017-3124-5
Autor:
Nicola Lehners, Maria Pritsch, Hartmut Goldschmidt, Elias K. Mai, Natalia Becker, Martin Löpprich, Jens Hillengass, Marc-Steffen Raab, Axel Benner
Publikováno v:
Cancer Medicine
The widespread use of high‐dose therapy and autologous stem cell transplantation (ASCT) as well as the introduction of novel agents have significantly improved outcomes in multiple myeloma (MM) enabling long‐term survival. We here analyze factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::732df9588eda51bf4dd5c770d179be29
http://europepmc.org/articles/PMC5806105
http://europepmc.org/articles/PMC5806105
Publikováno v:
Expert Review of Hematology. 9:753-765
Despite the progress made in the treatment of patients with multiple myeloma over recent decades, a significant cohort with high-risk disease as defined by specific clinical and genetic criteria continue to respond poorly to standard treatment. These
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ee6bd6be8d8a853e09bfb235ed5181f
https://doi.org/10.1080/17474086.2016.1204908
https://doi.org/10.1080/17474086.2016.1204908
Autor:
Andrej Besse, Andreas Rosenwald, Severin Fink, Matteo DaVia, Manik Chatterjee, Marc S. Raab, Isabel Cuenca, Clara Barrio-Garcia, Joaquin Martinez-Lopez, Andoni Garitano-Trojaola, A. Keith Stewart, Roland Beckmann, Nicola Lehners, Esteban Braggio, Thorsten Stühmer, Santiago Barrio, K. Martin Kortüm, Ellen Leich, Ralf C. Bargou, Christoph Driessen, Hermann Einsele
Publikováno v:
Leukemia. 33(2)
Despite an increasing number of approved therapies, multiple myeloma (MM) remains an incurable disease and only a small number of patients achieve prolonged disease control. Some genes have been linked with response to commonly used anti-MM compounds
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::995d36449bb1f12935cb8af48d7a6d1a
https://pubmed.ncbi.nlm.nih.gov/30026573
https://pubmed.ncbi.nlm.nih.gov/30026573